SCHEMBL9305074

SCHEMBL9305074

CC(C)=CCCC(C)=CCCCC(C(=O)O)P(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9304773 1.00
SCHEMBL9305065 1.00
SCHEMBL9304765 1.00
SCHEMBL9305368 0.96 FNTA (0.53)
SCHEMBL9305378 0.96 FNTA (0.53)
SCHEMBL8462990 0.91 FNTA (0.57)
SCHEMBL8462988 0.91 FNTA (0.57)
SCHEMBL8460925 0.85 FNTA (0.66)
SCHEMBL8461627 0.85 FNTA (0.66)
SCHEMBL8460264 0.85 FNTA (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0601573-A1 Alpha-phosphonocarboxylate squalene synthetase inhibitors and method BRISTOL-MYERS SQUIBB COMPANY (US) 1994-06-15 EP claimed
EP-0601573-A1 Alpha-phosphonocarboxylate squalene synthetase inhibitors and method BRISTOL-MYERS SQUIBB COMPANY (US) 1994-06-15 EP disclosed
US-5312814-A Antilipemic agents or anticholesterol agents BRISTOL-MYERS SQUIBB CO. (US) 1994-05-17 US disclosed